NMR-based screening in drug discovery.
Hajduk
P J
PJ
Pharmaceutical Discovery Division, Abbott Laboratories, Abbott Park, IL 60064, USA.
Meadows
R P
RP
Fesik
S W
SW
D055592:Biophysical Phenomena; D001703:Biophysics; D020650:Combinatorial Chemistry Techniques; D015195:Drug Design; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D006801:Humans; D008024:Ligands; D009682:Magnetic Resonance Spectroscopy; D061965:Matrix Metalloproteinase Inhibitors; D008780:Methyltransferases / Q000737:chemistry; D008958:Models, Molecular; D027383:Papillomaviridae / Q000737:chemistry; D022021:Tacrolimus Binding Proteins / Q000378:metabolism; D014764:Viral Proteins / Q000737:chemistry; D018909:src Homology Domains
D008024:Ligands; D061965:Matrix Metalloproteinase Inhibitors; D014764:Viral Proteins; D008780:Methyltransferases; C035181:rRNA (adenosine-O-2'-)methyltransferase; D022021:Tacrolimus Binding Proteins